Create a free Feed Strategy account to continue reading

BioMar revenue up 34%, volumes up 8% in first quarter

BioMar grew year-on-year volume sales by 8% in the first quarter of 2022, and the company reported revenue up by 34%.

Company says bottom line challenged by high costs, war in Ukraine, among others

BioMar grew year-on-year volume sales by 8% in the first quarter of 2022, and the company reported revenue up by 34%. While the top line is growing, the bottom line is challenged by raw material prices, cost of energy and the decision to suspend trading with Russia.

The significant increase in revenue in the first quarter was driven by higher sales volumes, raw material prices and, to some extent, currency rate development. However, earning was significant impacted by the sharp increase in raw material prices and energy cost not yet passed on to the customers.

Adding to the challenges after the Russian invasion of Ukraine, the earnings for the first quarter dropped due to a legal dispute in Norway and changed accounting policies for IT investments. EBITDA for Q1 2022 thus came to DKK54 mil­lion (US$7.7 million), compared with DKK133 million in Q1 2021.

BioMar lowers its guidance for the year 2022. The steep increase in prices on raw materials, freight and energy, is expected to continue. At the same time, BioMar has comprised the risk related to the suspended trading with Russia in the expected full-year-results. After the invasion of Ukraine, BioMar left the Russian market in terms of sales to Russia and in terms of sourcing of raw materials.

“We took a tough decision following our values when we suspended trading with Russia. Our sale in Russia has for years been a very important part of our business, especially for the BioMar units in Denmark and Norway. At the same time, we have sourced some of our key raw materials in the area now affected by the conflict. However, our customers must be able to rely on us as a business partner with high ethical standards,” said Carlos Diaz, CEO BioMar Group.

“The decision will take its toll at BioMar, but we are a part of society, and we need to take responsibility. My only concern – and surprise – is that some of our international competitors have not taken the same position but is rather taking advantage of the situation. But even knowing this, we would have taken the same decision, since it is the right thing to do. This is not a food crisis for the people in Russia, but a humanitarian crisis for the people in Ukraine.”

The decision to suspend trade with Russia has affected sales of finished goods as well as purchase prices for raw materials, as suppliers need to be substituted. At the beginning of the year, EBITDA was expected in the DKK980-1,040 million range. The international sanctions have increased the risk pertaining to receivables and other assets held in Russia. Against this background, BioMar now expects to generate full-year 2022 EBITDA in the DKK890-940 million range.

Page 1 of 178
Next Page